Molecular glue degraders: Lilly, AbbVie sign billion-dollar deals; BMS leads with three late-stage drugs

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

Cilostazol

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

39 API Suppliers, 11 USDMF, 14 JDMF, 5 EU WC, 24 KDMF, 6 NDC API, 21 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

12 Intermediate Suppliers

12 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

73 FDF Dossiers, 28 FDA Orange Book, 29 Europe, 16 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 3 DKSH, 6 Faran Shimi Pharmaceutical, 8 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 1 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 19 BASF, 10 Corel Pharma Chem, 7 DFE Pharma, 8 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 36 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 6 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 16 Roquette, 7 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 12 Sigachi Industries, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

67 Fillers, Diluents & Binders, 42 Coating Systems & Additives, 39 Disintegrants & Superdisintegrants, 29 Direct Compression, 27 Granulation, 24 Controlled & Modified Release, 18 Thickeners and Stabilizers, 16 Lubricants & Glidants, 13 Co-Processed Excipients, 10 Solubilizers, 9 Chewable & Orodispersible Aids, 9 Taste Masking, 6 Film Formers & Plasticizers, 5 Empty Capsules, 5 API Stability Enhancers, 5 Rheology Modifiers, 4 Vegetarian Capsules, 4 Emulsifying Agents, 3 Parenteral, 2 Coloring Agents, 1 Surfactant & Foaming Agents, 1 Topical

DIGITAL CONTENT

5 News #PharmaBuzz

5 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 22 Regulatory FDF Prices, 8 Annual Reports

MARKET PLACE

7 APIs

7 APIs

REF. STANDARDS & IMPURITIES

4 USP, 4 JP, 8 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
28/03/2025	Alivus Life Sciences	India	Ankuk Pharmaceutical Co., Ltd.	20050831-28-C-26-07(1)	Silostazol	2011-06-30	Glenmark Life Sciences Limited	India	Plot No. 3109-GIDC Industrial Estate ANKLESHWAR-393002 Dist. Bharuch, Gujarat, India
28/03/2025	Alivus Life Sciences	India	Sangjin Corporation	20050831-28-C-26-07	Silostazol	2005-08-31	Glenmark Life Sciences Limited	India	Plot No. 3109-GIDC Industrial Estate ANKLESHWAR-393002 Dist. Bharuch, Gujarat, India

Cilostazol

Cilostazol

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

39 API Suppliers

11 USDMF

14 JDMF

5 EU WC

24 KDMF

6 NDC API

21 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

INTERMEDIATES

12 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

73 FDF Dossiers

28 FDA Orange Book

29 Europe

16 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

4 SPI Pharma

3 DKSH

6 Faran Shimi Pharmaceutical

8 Boai NKY Pharmaceuticals Ltd

5 Gangwal Healthcare

1 Nanjing Well Pharmaceutical

1 ACG Worldwide

1 Aeon Procare

1 Alcedo Pharmachem

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

19 BASF

10 Corel Pharma Chem

7 DFE Pharma

8 Gangwal Chemicals

5 Ideal Cures Pvt Ltd

4 Ingredion Pharma Solutions

36 Kerry

3 Kima Chemical

6 Lonza Capsugel

13 Microlex e.U

3 Novo Excipients

4 Pharmatrans-Sanaq

6 Pluviaendo

5 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

16 Roquette

7 Seppic

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

12 Sigachi Industries

2 The Dow Chemical Company

2 Ulanqab Kema New Material

4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

67 Fillers, Diluents & Binders

42 Coating Systems & Additives

39 Disintegrants & Superdisintegrants

29 Direct Compression

27 Granulation

24 Controlled & Modified Release

18 Thickeners and Stabilizers

16 Lubricants & Glidants

13 Co-Processed Excipients

10 Solubilizers

9 Chewable & Orodispersible Aids

9 Taste Masking

6 Film Formers & Plasticizers

5 Empty Capsules

5 API Stability Enhancers

5 Rheology Modifiers

4 Vegetarian Capsules

TABLET;ORAL - 100MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 50MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons